Biomedical Consortium

BMRC (Biomedical Research Consortium-Chile) has been operating since 2007 for the purpose of developing and finding high-impact human health solutions through market-applicable and transferable R+D. The Consortium is funded by CORFO.

A thyroid cancer diagnostic test already available on the market was developed through this partnership.

Areas of R+D

• Diagnoses
• Treatments
• Vaccines

Partner Institutions

Pontificia Universidad Católica de Chile and Abbott, a US pharmaceutical company that bought out Recalcine as a means to gain access to the Latin-American market.